Multivitamins

What People Claim

The World's Most Purchased Supplement

Multivitamins are sold on the premise that they act as a nutritional "insurance policy" — a catch-all solution to bridge dietary gaps, boost energy, sharpen immunity, and offset the health risks of an imperfect diet.

"Most people are deficient in key nutrients. A daily multivitamin closes those gaps and keeps you protected."

"Taking a multivitamin every day reduces your cancer risk, protects your heart, and slows cognitive decline as you age."

"New research shows multivitamins can actually make you biologically younger — slowing the aging process at the cellular level."

The bigger claims frame multivitamins as longevity tools. The newest frontier involves epigenetic aging — emerging research suggests multivitamins may decelerate biological clocks, making users biologically younger over time. These claims are newer, more mechanistically plausible, and critically, supported by actual randomised controlled trial data rather than just observational epidemiology.

What the Evidence Shows

A Tale of Two Populations

All-Cause Mortality DEBUNKED

The largest study ever conducted on this question — Loftfield 2024, following 390,124 people for over 20 years across three US cohorts — found no mortality benefit from multivitamin use. There was a slight 4% early hazard signal, likely explained by "sick-quitter" bias: people often start taking multivitamins precisely when their health is already declining.

What would change this: A double-blind RCT with randomised multivitamin assignment (not self-selection) in a population confirmed deficient at baseline would test whether the null result holds when selection bias is eliminated.

CVD Prevention DEBUNKED

The Physicians Health Study II — 14,641 men followed for 11.2 years in a double-blind RCT — showed no reduction in cardiovascular events, strokes, or cardiac mortality. The US Preventive Services Task Force issued an I-statement (insufficient evidence to recommend) in 2022.

What would change this: An RCT specifically enrolling adults with confirmed low baseline micronutrient status, measuring endothelial function and cardiovascular endpoints over 10+ years.

Cancer Incidence MODERATE

PHS II found a statistically significant 8% reduction in cancer incidence in older male physicians (HR 0.92, p=0.044). This is a genuine signal from a rigorous double-blind RCT. However, it has not been replicated in women or in younger or more diverse populations, which is why the USPSTF couldn't make a broader recommendation.

What would change this: Replication in a diverse, mixed-sex population would elevate this to STRONG. Failure to replicate would weaken it to LOW.

Cognitive Function in Adults 65+ STRONG

This is the headline finding — and it's real. Three independent arms of the COSMOS trial (COSMOS-Web 2023, COSMOS-Clinic, COSMOS-Mind) have now consistently shown that adults over 65 taking a standard daily multivitamin preserved memory function equivalent to having a brain 1.8–3.1 years younger. Three independent arms converging on the same signal is strong evidence.

What would change this: Failure to replicate in a non-US population, or evidence that the benefit is driven by correcting specific baseline deficiencies rather than the multivitamin itself.

Epigenetic Aging Attenuation EMERGING

The COSMOS 2026 trial (Nature Medicine) found that Centrum Silver slowed biological aging as measured by two epigenetic clocks: PCGrimAge slowed by 1.4 months per year, and PCPhenoAge by 2.6 months per year over a 2-year RCT in adults over 60. This is mechanistically plausible — the triage theory of micronutrients predicts exactly this. But it's a single trial and needs independent replication before confidence is high.

What would change this: Independent replication in a larger, more diverse cohort would elevate this to STRONG. The mechanistic story is already compelling.

Micronutrient Deficiency Correction STRONG

NHANES biochemical data on 10,698 Americans shows that multivitamin use virtually eliminates blood-level inadequacy for Vitamin D (94% of Americans have suboptimal status), Vitamin E, Vitamin C, Vitamin A, and Zinc. This isn't a health outcome — it's confirming the supplement does what it says on the label. Whether correcting those deficiencies translates to downstream health outcomes is the more contested question.

What would change this: Nothing — the biochemistry of deficiency correction is not in dispute. The question is what those corrections mean for health outcomes.

Energy and General Wellness WEAK

There is no randomised controlled trial showing that well-nourished, non-deficient adults experience any measurable improvement in energy, mood, or general wellbeing from taking a multivitamin. The threshold model of micronutrient function explains why: if you're already at saturation, topping off doesn't do anything.

What would change this: An RCT specifically in adults with confirmed adequate baseline status showing a subjective or objective wellness improvement would be a genuine surprise.

How It Works

The Threshold Model vs The Dose-Response Myth

Most people assume that more nutrients = more benefit. Micronutrients don't work that way. They operate on a threshold model: up to the point of cellular saturation, each nutrient performs its biochemical job — acting as an enzyme cofactor, antioxidant, hormone precursor, DNA repair signal, or immune activator. Once the threshold is met, additional intake provides no extra benefit. For water-soluble vitamins, excess is simply excreted. For fat-soluble vitamins (A, D, E, K) and trace minerals, excess accumulates and can eventually cause toxicity.

The Debate

Where Studies Disagree

Current direction: The emerging consensus is population-segmented rather than all-or-nothing. Evidence is converging that adults 65+ benefit cognitively, deficient populations benefit from micronutrient correction, and the epigenetic aging data is becoming harder to dismiss. The null result for longevity in healthy well-nourished adults remains robust.

Real World vs Lab

What the Trials Can't Control For

Exactly How to Use It

The Protocol

Dosing by Population

Forms Comparison

Absorption Tips

• Always take with food containing fat — vitamins A, D, E, and K require bile salts and dietary fat for absorption. Fasted dosing severely reduces uptake of these four nutrients.
• Iron + calcium conflict — do not take a high-iron multivitamin alongside calcium supplements. Calcium blocks iron absorption by up to 60%. Space by 2+ hours.
• Methylated B-vitamins matter for 40% of people — MTHFR gene variants impair folic acid conversion. Look for methylated folate (5-MTHF) and methylcobalamin (B12) on the label for premium products.
• Natural vs synthetic Vitamin E — d-alpha-tocopherol (natural) has twice the bioavailability of dl-alpha-tocopherol (synthetic). Worth checking on the label.

Safety & Interactions

What to Watch For

Drug Interactions

Who Should Avoid Iron-Containing Multivitamins

Men and postmenopausal women generally do not need supplemental iron and should choose iron-free formulations. Individuals with hemochromatosis (an iron overload condition) must strictly avoid iron-containing products — iron in standard multivitamins bypasses normal absorptive regulation and accelerates cardiac and liver iron deposition.

Smokers or individuals with asbestos exposure: beta-carotene at supplemental doses paradoxically increases lung cancer incidence via pro-oxidant mechanisms in lung tissue (CARET trial). The USPSTF specifically recommends against beta-carotene supplementation in these populations.

Early pregnancy: Vitamin A in retinol form is highly harmful to the developing baby above 3,000 mcg RAE. Beta-carotene is safe. Always use pregnancy-specific prenatal formulas — they use beta-carotene, not retinol, for Vitamin A.

Side Effects at Standard Doses

The Nuance

What the Simple Answer Misses

The "just take a multivitamin" vs "multivitamins are useless" debate both miss the same thing: context is everything. The supplement is not the variable — the nutritional baseline of the person taking it is the variable.

Cost-Effectiveness

At £5–8/month for a standard tablet (the type actually used in clinical trials), multivitamins are one of the cheapest interventions available when the evidence supports their use. For the populations that benefit — 65+, deficient individuals, vegans, pregnant women — the value-to-cost ratio is strong.

For healthy adults under 65 with a solid diet seeking specific outcomes: targeted individual supplements are more cost-effective and precise. D3 (2000 IU) + Magnesium (300–400mg) + B12 (if dietary intake is low) costs approximately £10–15/month and delivers therapeutic doses where a multivitamin's quantities are often pharmacologically underpowered.